Penny Stock InVivo Therapeutics Holdings Corp. (OTC: NVIV), developer of groundbreaking technologies for the treatment of spinal cord injuries, is to be spotlighted on Fox News next week. NVIV had a rough day yesterday having touched $2.94 intraday before closing more than $0.50 lower at ...
17
FEB
FEB
0
Share
